Skip to content
Study details
Enrolling now

Cannabis for Palliative Care in Cancer

University of Colorado, Boulder
NCT IDNCT06266611ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

185

Study length

about 3.8 years

Ages

25+

Locations

1 site in CO

About this study

Researchers are testing a treatment with hemp-derived CBD (Cannabidiol) and THC (Delta-9-tetrahydrocannabinol), or placebo, to see if it helps with pain, sleep, mood, cognitive function, and quality of life in adults with cancer. The trial will last for 1383 days.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Take Placebo
  • 2.Take bsCBD Cannabidiol
  • 3.Take fsCBD Cannabidiol
PhasePhase 2
DrugfsCBD Cannabidiol
Routeoral
Primary goalFatigue

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low9%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Drug routes

oral (Oral Solution)

Endpoints

Primary: Fatigue, Health Related Quality of Life, PROMIS Pain Intensity (Right Now), Pain Intensity, Pain Interference, Pain Inventory

Secondary: Polypharmacy for Pain

Body systems

Psychiatry / Mental Health